Skip to main content
Figure 7 | BMC Infectious Diseases

Figure 7

From: Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors

Figure 7

Increased plasma bile acids are associated with intermediate/high FIB-4 and APRI scores and high YKL-40. Bar graphs showing bile acid levels (scaled intensity) in healthy controls (white), and HIV subjects with low (pink) vs. intermediate/high FIB-4 or APRI scores or high YKL-40 levels (red). P-values were calculated using Welch’s t-tests.

Back to article page